Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma
Iman Seyhoun
Iman Seyhoun

Assistant Professor of Applied Cellular Sciences

Department Tissue Engineering and Applied Cellular Sciences

School of Advanced Technologies in Medicine

Iranian Tissue Bank & Research Center

Tehran University of Medical Sciences

All Documents
1. Impact of Organ Donation on Grief Symptoms in Donor Families, BMC Psychology (2025)
2. Regeneration of Bone Tissue Using Nanofibers Made From Electrospun Polycaprolactone (Pcl) and a Hydrogel Composed of Alginate (Alg/Pcl), Regenerative Engineering and Translational Medicine (2025)
3. Review of Mesenchymal Stem Cell-Derived Exosomes and Their Potential Therapeutic Roles in Treating Rheumatoid Arthritis, Molecular Biology Reports (2025)
4. Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma, Advanced Pharmaceutical Bulletin (2025)
5. Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma, Advanced Pharmaceutical Bulletin (2025)
6. Cell Therapy Using Anti-Nkg2a Pretreated Natural Killer Cells in Patients With Hepatocellular Carcinoma, Advanced Pharmaceutical Bulletin (2024)
7. Long-Term Graft Survival in a Kidney Transplant Recipient With Glioblastoma: Case Report, Transplantation Reports (2024)
8. Chemo-Immune Cell Therapy by Intratumoral Injection of Adoptive Nk Cells With Capecitabine in Gastric Cancer Xenograft Model, BioImpacts (2023)
9. Recent Advances in Mesenchymal Stem/Stromal Cells (Mscs)-Based Approaches for Osteoarthritis (Oa) Therapy, Cell Biology International (2023)
10. Anti-Inflammatory Effect of Mesenchymal Stem Cells on Hepatocellular Carcinoma in the Xenograft Mice Model, Veterinary Medicine and Science (2022)
11. Development and Clinical Application of Tumor-Derived Exosomes in Patients With Cancer, Current Stem Cell Research and Therapy (2022)
12. The Effects of Sorafenib and Natural Killer Cell Co-Injection in Combinational Treatment of Hepatocellular Carcinoma; an in Vivo Approach, Pharmacological Reports (2022)
13. Cell Therapy in Patients With Covid-19 Using Wharton’S Jelly Mesenchymal Stem Cells: A Phase 1 Clinical Trial, Stem Cell Research and Therapy (2021)
14. Implication for Prevention and Control of Cardiovascular Disease; an Experience From Iran, Scientific Journal of Kurdistan University of Medical Sciences (2021)
15. Therapeutic Approach of Adipose-Derived Mesenchymal Stem Cells in Refractory Peptic Ulcer, Stem Cell Research and Therapy (2021)
16. Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of Hcc, Evidence-based Complementary and Alternative Medicine (2020)
17. Combination Therapy of Sorafenib With Mesenchymal Stem Cells As a Novel Cancer Treatment Regimen in Xenograft Models of Hepatocellular Carcinoma, Journal of Cellular Physiology (2019)
18. Natural Killer Cell Expansion With Autologous Feeder Layer and Anti-Cd3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma, Asian Pacific Journal of Cancer Prevention (2019)
19. Novel Combination of Mesenchymal Stem Cell-Conditioned Medium With Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells, Asian Pacific Journal of Cancer Prevention (2019)
20. Combinational Immune? Cell Therapy of Natural Killer Cells and Sorafenib for Advanced Hepatocellular Carcinoma: A Review, Cancer Cell International (2018)